Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer

Advanced Drug Delivery Reviews(2023)10.1016/j.addr.2023.115083Source: DataRank Database

Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer is a research paper published in Advanced Drug Delivery Reviews (2023). On theSindex it has a DataRank of 0. It has been cited 189 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access189 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 15.58)OA: greenTopics (30)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Robert Morhard ORCID,Michal Mauda‐Havakuk ORCID,Michael Kassin ORCID,Antonio Arrichiello ORCID,Bradford J. Wood ORCID

Live enrichment

PubMed:37673217 PMC:PMC11616795 OpenAlex:https://openalex.org/W4386505337

National Institutes of Health

Grant: Z01 1ZID BC011242

National Institutes of Health

Grant: CL040015

Intramural NIH HHS

Grant: ZID BC011242

Intramural NIH HHS

Grant: Z99 CL999999

Intramural NIH HHS

Grant: ZIA CL040015

FWCI

15.58

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11616795/pdf/nihms-1935377.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0169409X23003988?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169409X23003988?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11616795

Fields of Study

Nanoplatforms for cancer theranosticsImmunotherapy and Immune ResponsesNanoparticle-Based Drug DeliveryHumansDelayed-Action PreparationsHydrogelsDrug Delivery SystemsNeoplasmsImmunotherapyTumor Microenvironment

MeSH Terms

Delayed-Action PreparationsHumansImmunotherapyNeoplasmsDrug Delivery SystemsHydrogelsTumor Microenvironment

Keywords

ImmunotherapyDrug deliveryMedicineTumor microenvironmentDrugImmune systemCancer immunotherapyAbscopal effectCancer researchPharmacologyImmunologyNanotechnologyMaterials science

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma

10.6084/m9.figshare.26735679.v1figshare

Additional file 1 of Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma

10.6084/m9.figshare.26735679figshare